Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-180614
Filing Date
2017-05-24
Accepted
2017-05-24 08:56:03
Documents
5
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 6-K d400062d6k.htm 6-K 14389
2 EX-1.1 d400062dex11.htm EX-1.1 180046
3 EX-5.1 d400062dex51.htm EX-5.1 22989
4 GRAPHIC g400062imagee1.jpg GRAPHIC 19782
5 GRAPHIC g400062img2.jpg GRAPHIC 6617
  Complete submission text file 0001193125-17-180614.txt   255029
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 17865551
SIC: 2834 Pharmaceutical Preparations